XML 33 R17.htm IDEA: XBRL DOCUMENT

Stock Transactions	9 Months Ended
Jun. 30, 2015
Notes to Financial Statements
Stock Transactions	NOTE 11. STOCK TRANSACTIONS Bio- Matrix Scientific Group, Inc.: On April 13, 2015 the company issued 200,000,000 Common Shares in satisfaction of $20,000 of indebtedness. Regen Biopharma, Inc.: Common Stock On April 14, 2015 Regen Biopharma, Inc. issued 1,428, 571 of its common shares in satisfaction of $40,000 of convertible indebtedness. On May 12, 2015 Regen Biopharma, Inc. issued 500,000 of its common shares in satisfaction of $15,000 of indebtedness. On May 18, 2015 Regen Biopharma, Inc. issued 500,000 of its common shares in satisfaction of $15,000 of indebtedness. On May 19, 2015 Regen Biopharma, Inc. issued 1,785,714 of its common shares in satisfaction of $50,000 of convertible indebtedness. Series A Preferred Stock On April 14, 2015 Regen Biopharma, Inc. issued 1,428, 571 of its shares of Series A Preferred Stock in accordance with the terms and conditions of a $40,000 face value convertible note issued by Regen Biopharma, Inc.. On May 19, 2015 Regen Biopharma, Inc. issued 200,000 of its shares of Series A Preferred Stock as consideration for services rendered by nonemployees. On May 19, 2015 Regen Biopharma, Inc. issued 1,785,714 of its shares of Series A Preferred Stock in accordance with the terms and conditions of a $50,000 face value convertible note issued by Regen Biopharma, Inc..

Stock Transactions

9 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Stock Transactions

NOTE 11. STOCK TRANSACTIONS

Bio- Matrix Scientific Group, Inc.:

On April 13, 2015 the company issued 200,000,000 Common Shares in satisfaction of $20,000 of indebtedness.

Regen Biopharma, Inc.:

Common Stock

On April 14, 2015 Regen Biopharma, Inc. issued 1,428, 571 of its common shares in satisfaction of $40,000 of convertible indebtedness.

On May 12, 2015 Regen Biopharma, Inc. issued 500,000 of its common shares in satisfaction of $15,000 of indebtedness.

On May 18, 2015 Regen Biopharma, Inc. issued 500,000 of its common shares in satisfaction of $15,000 of indebtedness.

On May 19, 2015 Regen Biopharma, Inc. issued 1,785,714 of its common shares in satisfaction of $50,000 of convertible indebtedness.

Series A Preferred Stock

On April 14, 2015 Regen Biopharma, Inc. issued 1,428, 571 of its shares of Series A Preferred Stock in accordance with the terms and conditions of a $40,000 face value convertible note issued by Regen Biopharma, Inc..

On May 19, 2015 Regen Biopharma, Inc. issued 200,000 of its shares of Series A Preferred Stock as consideration for services rendered by nonemployees.

On May 19, 2015 Regen Biopharma, Inc. issued 1,785,714 of its shares of Series A Preferred Stock in accordance with the terms and conditions of a $50,000 face value convertible note issued by Regen Biopharma, Inc..